$ENRT
Enertopia Corp.

2025 Q1 Form 10-Q Financial Statement

#000106299325000717 Filed on January 13, 2025

View on sec.gov

Income Statement

Concept 2025 Q1 2024 Q4 2024 Q3
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $22.95K
YoY Change -74.01%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $93.02K
YoY Change -62.99%
Operating Profit -$93.02K
YoY Change -62.99%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $12.59K
YoY Change 2775.34%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$83.13K
YoY Change -79.71%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 155.2M shares 155.2M shares 155.2M shares
Diluted Shares Outstanding 155.2M shares

Balance Sheet

Concept 2025 Q1 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $152.8K $247.4K
YoY Change -82.28% -80.19%
Cash & Equivalents $152.8K $179.9K
Short-Term Investments $0.00 $67.52K
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $47.59K $78.79K
Receivables $7.518K $5.927K
Other Receivables
Total Short-Term Assets $207.9K $332.1K
YoY Change -77.48% -75.36%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $11.00K $10.50K
YoY Change 4.76% 0.0%
TOTAL ASSETS
Total Short-Term Assets $207.9K $332.1K
Total Long-Term Assets $11.00K $10.50K
Total Assets $218.9K $342.6K
YoY Change -76.56% -74.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $274.9K $316.0K
YoY Change -8.57% 0.2%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $274.9K $316.0K
YoY Change -13.51% -4.98%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $274.9K $316.0K
Total Long-Term Liabilities
Total Liabilities $316.0K
YoY Change -4.98%
SHAREHOLDERS EQUITY
Retained Earnings -$15.61M -$15.52M
YoY Change 4.5% 6.87%
Common Stock $155.2K $155.2K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$55.27K $27.81K
YoY Change
Total Liabilities & Shareholders Equity $218.4K $342.6K
YoY Change -76.61% -74.77%

Cashflow Statement

Concept 2025 Q1 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$83.13K
YoY Change -79.71%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$103.1K
YoY Change -55.18%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $75.95K
YoY Change -65.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -$103.1K
Cash From Investing Activities $75.95K
Cash From Financing Activities
Net Change In Cash -$27.13K
YoY Change 138.04%
FREE CASH FLOW
Cash From Operating Activities -$103.1K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
152768 usd
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
155167 usd
CY2024Q4 dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 us-gaap Assets Current
AssetsCurrent
332130 usd
CY2024Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
VIY 4R2
CY2024Q4 dei Entity File Number
EntityFileNumber
000-51866
CY2024Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7518 usd
CY2024Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
47587 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
78794 usd
CY2024Q4 us-gaap Assets Current
AssetsCurrent
207873 usd
CY2024Q3 us-gaap Mineral Properties Net
MineralPropertiesNet
10500 usd
CY2024Q3 us-gaap Assets
Assets
342630 usd
CY2024Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15608047 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15524969 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
27805 usd
CY2024Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
218373 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
342630 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1025608 usd
CY2023Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-292 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-409456 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
615860 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-130 usd
CY2024Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1591 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-147402 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
468328 usd
CY2024Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-52 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-287901 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
180375 usd
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-52 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-153725 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26598 usd
CY2024Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-52 usd
CY2024Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-83078 usd
CY2024Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-56532 usd
CY2024Q4 enrt Marketable Securities Unrealized Foreign Exchange Loss
MarketableSecuritiesUnrealizedForeignExchangeLoss
0 usd
CY2023Q4 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-20640 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5088 usd
CY2024Q4 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-31207 usd
CY2023Q4 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-42677 usd
CY2024Q4 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
75947 usd
CY2024Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
75947 usd
CY2024Q4 enrt Number Of Shares Held In Escrow Under Process To Release
NumberOfSharesHeldInEscrowUnderProcessToRelease
2500000 shares
CY2023Q4 enrt Rent Expense
RentExpense
2440 usd
CY2024Q3 us-gaap Noncurrent Assets
NoncurrentAssets
10500 usd
CY2024Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
Kelowna
CY2024Q3 us-gaap Marketable Securities
MarketableSecurities
67516 usd
CY2024Q4 us-gaap Common Stock Value
CommonStockValue
155167 usd
CY2024Q4 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
0 usd
CY2023Q4 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-37 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
179893 usd
CY2024Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2024Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
155166088 shares
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-11395 usd
CY2024Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-103072 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-229950 usd
CY2024Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15608047 usd
CY2024Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
155166088 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
155166088 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
155166088 shares
CY2024Q4 enrt Number Of Shares Held In Escrow
NumberOfSharesHeldInEscrow
7000000 shares
CY2024Q3 enrt Number Of Shares Held In Escrow
NumberOfSharesHeldInEscrow
7000000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8150000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.09
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8150000 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.09
CY2024Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8150000 shares
CY2024Q4 enrt Rental Commitment
RentalCommitment
853 cad
CY2024Q4 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2024Q4 us-gaap Noncurrent Assets
NoncurrentAssets
10500 usd
CY2024Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
#7 1873 Spall Road
CY2024Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15397607 usd
CY2024Q4 us-gaap Members Equity Attributable To Noncontrolling Interest
MembersEquityAttributableToNoncontrollingInterest
-1259 usd
CY2024Q3 us-gaap Members Equity Attributable To Noncontrolling Interest
MembersEquityAttributableToNoncontrollingInterest
-1207 usd
CY2024Q4 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
16711 usd
CY2023Q4 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
48211 usd
CY2024Q4 us-gaap Other Expenses
OtherExpenses
12594 usd
CY2023Q4 us-gaap Other Expenses
OtherExpenses
438 usd
CY2024Q4 us-gaap Advertising Expense
AdvertisingExpense
3124 usd
CY2023Q4 us-gaap Advertising Expense
AdvertisingExpense
9946 usd
CY2024Q4 us-gaap Legal Fees
LegalFees
4065 usd
CY2023Q4 us-gaap Legal Fees
LegalFees
26605 usd
CY2024Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18606 usd
CY2024Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-83078 usd
CY2024Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-52 usd
CY2023Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-292 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
218555 usd
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0 shares
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
CY2024Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8150000 shares
CY2024Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y7M28D
CY2024Q4 enrt Rent Expense
RentExpense
1878 usd
CY2024Q4 enrt Prepaid Expenses Current Exploration Costs
PrepaidExpensesCurrentExplorationCosts
14183 usd
CY2024Q4 enrt Prepaid Expenses Current Office Expenses
PrepaidExpensesCurrentOfficeExpenses
928 usd
CY2024Q4 dei Entity Central Index Key
EntityCentralIndexKey
0001346022
CY2024Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--08-31
CY2024Q4 dei Document Type
DocumentType
10-Q
CY2024Q4 dei Document Period End Date
DocumentPeriodEndDate
2024-11-30
CY2024Q4 dei Entity Registrant Name
EntityRegistrantName
Enertopia Corporation
CY2024Q4 us-gaap Assets
Assets
218873 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
316032 usd
CY2024Q4 us-gaap Liabilities Current
LiabilitiesCurrent
274905 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
316032 usd
CY2024Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
155166088 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
155166088 shares
CY2023Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-409456 usd
CY2024Q4 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
377803 usd
CY2023Q4 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
183690 usd
CY2024Q4 us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
352239 usd
CY2023Q4 us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
327784 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-229950 usd
CY2024Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15397607 usd
CY2024Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-1970188
CY2024Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
BC
CY2024Q4 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q4 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5927 usd
CY2024Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
10500 usd
CY2024Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
274905 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
155166088 shares
CY2024Q4 us-gaap Professional Fees
ProfessionalFees
6486 usd
CY2023Q4 us-gaap Professional Fees
ProfessionalFees
14518 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17701 usd
CY2024Q4 enrt Mineral Exploration Costs
MineralExplorationCosts
8490 usd
CY2023Q4 enrt Mineral Exploration Costs
MineralExplorationCosts
45652 usd
CY2024Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22948 usd
CY2023Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
88300 usd
CY2024Q4 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1463 usd
CY2023Q4 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1406 usd
CY2024Q4 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-352239 usd
CY2023Q4 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-327784 usd
CY2024Q4 enrt Marketable Securities Realized Foreign Exchange Loss
MarketableSecuritiesRealizedForeignExchangeLoss
-17133 usd
CY2024Q4 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
377803 usd
CY2023Q4 enrt Marketable Securities Unrealized Foreign Exchange Loss
MarketableSecuritiesUnrealizedForeignExchangeLoss
7763 usd
CY2024Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0
CY2024Q4 us-gaap Net Income Loss
NetIncomeLoss
-83130 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-409748 usd
CY2023Q4 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
7763 usd
CY2024Q4 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-17133 usd
CY2024Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-41127 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-14725 usd
CY2024Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-103072 usd
CY2023Q4 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
218555 usd
CY2024Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-27125 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
259581 usd
CY2024Q4 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q4 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024Q4 us-gaap Cash
Cash
61199 usd
CY2024Q3 us-gaap Cash
Cash
61048 usd
CY2024Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
152768 usd
CY2024Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
88300 usd
CY2024Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
155166088 shares
CY2023Q4 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2024Q4 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2024Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.09
CY2024Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y7M28D
CY2024Q4 enrt Prepaid Expenses Current Consultants
PrepaidExpensesCurrentConsultants
6000 usd
CY2024Q3 enrt Prepaid Expenses Current Consultants
PrepaidExpensesCurrentConsultants
12000 usd
CY2024Q3 enrt Prepaid Expenses Current Exploration Costs
PrepaidExpensesCurrentExplorationCosts
22673 usd
CY2024Q4 enrt Prepaid Expenses Fees And Dues
PrepaidExpensesFeesAndDues
3996 usd
CY2024Q3 enrt Prepaid Expenses Fees And Dues
PrepaidExpensesFeesAndDues
9256 usd
CY2024Q4 us-gaap Prepaid Insurance
PrepaidInsurance
22480 usd
CY2024Q3 us-gaap Prepaid Insurance
PrepaidInsurance
33720 usd
CY2024Q3 enrt Prepaid Expenses Current Office Expenses
PrepaidExpensesCurrentOfficeExpenses
1145 usd
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
-55273 usd
CY2024Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-56532 usd
CY2024Q4 us-gaap Operating Expenses
OperatingExpenses
93024 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
251371 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-251371 usd
CY2024Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
155166088 shares
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
155166088 shares
CY2024Q4 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
0 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
179893 usd
CY2024Q4 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-left:18pt;text-align:justify;margin-top:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>d.</strong> <strong>Accounting Estimates</strong></span></span></p> <p style="margin-left:18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of financial statements in conformity with U.S GAAP requires us to make certain estimates, judgements and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Some of the Company's accounting policies require us to make subjective judgments, often as a result of the need to make estimates of matters that are inherently uncertain. These accounting policies involve critical accounting estimates because they are particularly dependent on estimates and assumptions made by management about matters that are highly uncertain at the time the accounting estimates are made. Although we have used our best estimates based on facts and circumstances available to us at the time, different estimates reasonably could have been used. Changes in the accounting estimates used by the Company are reasonably likely to occur from time to time, which may have a material effect on the presentation of financial condition and results of operations.</span></span></p> <p style="margin-left:18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company reviews these estimates, judgments, and assumptions periodically and reflect the effects of revisions in the period in which they are deemed to be necessary. We believe that these estimates are reasonable; however, actual results could differ from these estimates.</span></span></p> <p style="margin-left:18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Significant accounting estimates and assumptions are used for, but not limited to:</span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a) The Valuation of Deferred Tax Assets</span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Judgement is required in determining whether deferred tax assets are recognized on the balance sheet. The recognition of deferred tax assets requires management to assess the likelihood that the Company will generate taxable income in future periods to utilize the deferred tax assets. Due to the Company's history of losses, deferred tax assets have not been recognized by the Company.</span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b) Value of Stock Options</span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company provides compensation benefits to its employees, directors, officers, and consultants, through a stock option plan. The fair value of each option award is estimated on the date of grant using the Black-Scholes option pricing model. Expected volatility assumption used in the model is based on the historical volatility of the Company's share price. The Company uses historical data to estimate the period of option exercises for use in the valuation model. The risk-free interest rate for the expected term of the option is based on the yields of government bonds. Changes in these assumptions, especially the share price volatility and the expected life determination could have a material impact on the Company's profit and loss for the periods presented. All estimates used in the model are based on historical data which may not be representative of future results.</span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c) Fair value of shares issued in non-cash transactions</span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company at times grants common shares in lieu of cash to certain vendors for their services to the Company. The Company recognizes the associated cost in the same period and manner as if the Company paid cash for the services provided by calculating the fair value of the share offering at the cost of the service provided.</span></span></p> </div>
CY2024Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22948 usd
CY2024Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0 shares
CY2024Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
CY2024Q4 dei Amendment Flag
AmendmentFlag
false
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26598 usd
CY2024Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-93024 usd
CY2023Q4 enrt Marketable Securities Realized Foreign Exchange Loss
MarketableSecuritiesRealizedForeignExchangeLoss
-20640 usd
CY2023Q4 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
183690 usd
CY2024Q4 us-gaap Net Income Loss
NetIncomeLoss
-83130 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-409748 usd
CY2024Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0
CY2024Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
155166088 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
155166088 shares
CY2024Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
91569 usd
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
118845 usd
CY2024Q4 enrt Geologists Expenses
GeologistsExpenses
0 usd
CY2023Q4 enrt Geologists Expenses
GeologistsExpenses
21175 usd
CY2024Q4 enrt Sample Assays
SampleAssays
0 usd
CY2023Q4 enrt Sample Assays
SampleAssays
13307 usd
CY2024Q4 enrt Travel And Other Expenses
TravelAndOtherExpenses
8490 usd
CY2023Q4 enrt Travel And Other Expenses
TravelAndOtherExpenses
11171 usd
CY2024Q4 us-gaap Exploration Expense
ExplorationExpense
8490 usd
CY2023Q4 us-gaap Exploration Expense
ExplorationExpense
45652 usd
CY2024Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
47587 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
78794 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
248186 usd
CY2024Q4 dei City Area Code
CityAreaCode
250
CY2024Q4 dei Local Phone Number
LocalPhoneNumber
870-2219
CY2025Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
155166088 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
179893 usd
CY2024Q4 us-gaap Marketable Securities
MarketableSecurities
0 usd
CY2024Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
152768 usd

Files In Submission

Name View Source Status
0001062993-25-000717-index-headers.html Edgar Link pending
0001062993-25-000717-index.html Edgar Link pending
0001062993-25-000717.txt Edgar Link pending
0001062993-25-000717-xbrl.zip Edgar Link pending
enrt-20241130.xsd Edgar Link pending
exhibit31-1.htm Edgar Link pending
exhibit31-2.htm Edgar Link pending
exhibit32-1.htm Edgar Link pending
exhibit32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10q_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
enrt-20241130_lab.xml Edgar Link unprocessable
enrt-20241130_def.xml Edgar Link unprocessable
enrt-20241130_cal.xml Edgar Link unprocessable
enrt-20241130_pre.xml Edgar Link unprocessable